Re: Jochen Walz. The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis? Eur Urol 2018;73:31-2

Eur Urol. 2018 Jun;73(6):e151-e152. doi: 10.1016/j.eururo.2018.02.003. Epub 2018 Feb 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Prostatic Neoplasms*